Catherine D. Moser

55.0k total citations
36 papers, 1.2k citations indexed

About

Catherine D. Moser is a scholar working on Molecular Biology, Surgery and Cell Biology. According to data from OpenAlex, Catherine D. Moser has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Surgery and 7 papers in Cell Biology. Recurrent topics in Catherine D. Moser's work include Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Fibroblast Growth Factor Research (8 papers) and Liver physiology and pathology (5 papers). Catherine D. Moser is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Fibroblast Growth Factor Research (8 papers) and Liver physiology and pathology (5 papers). Catherine D. Moser collaborates with scholars based in United States, China and South Korea. Catherine D. Moser's co-authors include Lewis R. Roberts, Abdirashid M. Shire, Ileana Aderca, Chunling Hu, Chunrong Yu, Abdul M. Oseini, Alex A. Adjei, Schuyler O. Sanderson, Tao Han and Megan Garrity-Park and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

Catherine D. Moser

35 papers receiving 1.1k citations

Peers

Catherine D. Moser
Tong‐Chun Xue China
Arihiro Aihara Japan
Qiong Xue China
Jorge A. Almenara United States
Francisco Mansilla Denmark
Zhenggang Ren China
Michele Goyette United States
Marcella Sini Italy
Ariel Ka-Man Chow Hong Kong
Kwan Man Hong Kong
Tong‐Chun Xue China
Catherine D. Moser
Citations per year, relative to Catherine D. Moser Catherine D. Moser (= 1×) peers Tong‐Chun Xue

Countries citing papers authored by Catherine D. Moser

Since Specialization
Citations

This map shows the geographic impact of Catherine D. Moser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine D. Moser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine D. Moser more than expected).

Fields of papers citing papers by Catherine D. Moser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine D. Moser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine D. Moser. The network helps show where Catherine D. Moser may publish in the future.

Co-authorship network of co-authors of Catherine D. Moser

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine D. Moser. A scholar is included among the top collaborators of Catherine D. Moser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine D. Moser. Catherine D. Moser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Xiwei, Catherine D. Moser, Chunling Hu, et al.. (2022). Establishment and Characterization of a New Human Intrahepatic Cholangiocarcinoma Cell Line LIV27. Cancers. 14(20). 5080–5080. 1 indexed citations
2.
Carr, Ryan M., Paola Romecín, Ezequiel J. Tolosa, et al.. (2020). The extracellular sulfatase SULF2 promotes liver tumorigenesis by stimulating assembly of a promoter-looping GLI1-STAT3 transcriptional complex. Journal of Biological Chemistry. 295(9). 2698–2712. 12 indexed citations
3.
Ha, Yeonjung, Yong Fang, Paola Romecín, et al.. (2019). Induction of Lysosome‐associated Protein Transmembrane 4 Beta via Sulfatase 2 Enhances Autophagic Flux in Liver Cancer Cells. Hepatology Communications. 3(11). 1520–1543. 4 indexed citations
4.
Miyabe, Katsuyuki, Yu Wang, Dehai Wu, et al.. (2018). Preclinical In Vitro and In Vivo Evidence of an Antitumor Effect of CX-4945, a Casein Kinase II Inhibitor, in Cholangiocarcinoma. Translational Oncology. 12(1). 143–153. 35 indexed citations
5.
Roberts, Rosebud O., Chunling Hu, Catherine D. Moser, et al.. (2017). Decreased Expression of Sulfatase 2 in the Brains of Alzheimer’s Disease Patients: Implications for Regulation of Neuronal Cell Signaling. Journal of Alzheimer s Disease Reports. 1(1). 115–124. 15 indexed citations
6.
7.
Nakamura, Ikuo, Bubu A. Banini, Tae Hyo Kim, et al.. (2014). Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling. PLoS ONE. 9(4). e92273–e92273. 49 indexed citations
8.
Dhanasekaran, Renumathy, Ikuo Nakamura, Chunling Hu, et al.. (2014). Activation of the transforming growth factor‐β/SMAD transcriptional pathway underlies a novel tumor‐promoting role of sulfatase 1 in hepatocellular carcinoma. Hepatology. 61(4). 1269–1283. 42 indexed citations
9.
Riordan, Jesse D., Vincent W. Keng, Barbara R. Tschida, et al.. (2013). Identification of Rtl1, a Retrotransposon-Derived Imprinted Gene, as a Novel Driver of Hepatocarcinogenesis. PLoS Genetics. 9(4). e1003441–e1003441. 70 indexed citations
10.
Nakamura, Ikuo, Maite G. Fernández‐Barrena, M. Clara Ortíz, et al.. (2013). Activation of the Transcription Factor GLI1 by WNT Signaling Underlies the Role of SULFATASE 2 as a Regulator of Tissue Regeneration. Journal of Biological Chemistry. 288(29). 21389–21398. 28 indexed citations
11.
Zheng, Xin, Natalia Belén Rumie Vittar, Xiaohong Gai, et al.. (2012). The Transcription Factor GLI1 Mediates TGFβ1 Driven EMT in Hepatocellular Carcinoma via a SNAI1-Dependent Mechanism. PLoS ONE. 7(11). e49581–e49581. 63 indexed citations
12.
Chaiteerakij, Roongruedee, Brian D. Juran, Catherine D. Moser, et al.. (2012). 696 Lack of Association Between NKG2D Polymorphisms and Cholangiocarcinoma (CCA) Risk in Primary Sclerosing Cholangitis (PSC) and Non-PSC Patients. Gastroenterology. 142(5). S–922. 1 indexed citations
13.
14.
Oseini, Abdul M., Roongruedee Chaiteerakij, Abdirashid M. Shire, et al.. (2011). Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology. 54(3). 940–948. 131 indexed citations
15.
Lai, Jin-Ping, Dalbir S. Sandhu, Chunrong Yu, et al.. (2010). Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors. Liver International. 30(10). 1522–1528. 26 indexed citations
16.
Oseini, Abdul M., Catherine D. Moser, Chunrong Yu, et al.. (2010). The Oncogenic Effect of Sulfatase 2 in Human Hepatocellular Carcinoma Is Mediated in Part by Glypican 3–Dependent Wnt Activation. Hepatology. 52(5). 1680–1689. 93 indexed citations
17.
Sandhu, Dalbir S., Catherine D. Moser, Sophie C. Cazanave, et al.. (2009). Additive effect of apicidin and doxorubicin in sulfatase 1 expressing hepatocellular carcinoma in vitro and in vivo. Journal of Hepatology. 50(6). 1112–1121. 28 indexed citations
18.
Lai, Jinping, Dalbir S. Sandhu, Chunrong Yu, et al.. (2008). Sulfatase 2 up‐regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma†. Hepatology. 47(4). 1211–1222. 168 indexed citations
19.
Aderca, Ileana, Catherine D. Moser, Ahmad BaniHani, et al.. (2008). The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX. Journal of Hepatology. 49(3). 373–383. 43 indexed citations
20.
Lai, Jinping, Chunrong Yu, Catherine D. Moser, et al.. (2006). SULF1 Inhibits Tumor Growth and Potentiates the Effects of Histone Deacetylase Inhibitors in Hepatocellular Carcinoma. Gastroenterology. 130(7). 2130–2144. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tong‐Chun Xue Breakdown of academic impact, for papers by Arihiro Aihara Breakdown of academic impact, for papers by Qiong Xue Breakdown of academic impact, for papers by Jorge A. Almenara Breakdown of academic impact, for papers by Francisco Mansilla Breakdown of academic impact, for papers by Zhenggang Ren Breakdown of academic impact, for papers by Michele Goyette Breakdown of academic impact, for papers by Marcella Sini Breakdown of academic impact, for papers by Ariel Ka-Man Chow Breakdown of academic impact, for papers by Kwan Man
Rankless by CCL
2026